ArticleThe international journal of cardiovascular imaging2025
Misclassification of recovery in dilated cardiomyopathy by echocardiography as compared to cardiac MRI.
Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurate assessment of cardiac function is the cornerstone of DCM diagnosis and management. Studies have compared CMR and 2D-TTE but the impact of these measurements on HF classification and assessment of EF improvement has not been explored. We aim to compare left ventricular (LV) ejection fraction (EF) and volumes as measured by cardiovascular magnetic resonance (CMR) and two dimensional (2D) transthoracic echocardiography (TTE) in dilated cardiomyopathy (DCM) patients in the initial EF based classification of heart failure (HF) and subsequent follow-up.We compared LVEF, LV end-diastolic volume (LVEDV) and LV end-systolic volumes (ESV) measurements from 130 DCM patients during both their initial visit and their follow-up imaging 12-48 months later. We also assessed the myocardial recovery of patients who were classified as having HFimpEF (EF < 40% to EF ≥ 40% with at least a 10% increase in EF) by 2D-TTE and CMR. We found that 2D-TTE overestimated EF (8.3% (95% CI 7.2 to 9.4), p < 0.001) and underestimated LVEDV (-69.0 ml (95% CI -77.0 to -61.1), p < 0.001) and LVESV (-64.8 ml (95% CI -71.6 to -57.9) p < 0.001) as compared to CMR. The overestimation of EF was not uniform across the EF spectrum. The lower the LVEF, the greater the overestimation by TTE. This overestimation led to an initial misclassification of 60% of HFrEF patients and a subsequent misclassification of myocardial recovery in 59% of DCM patients. 2D-TTE misclassification of DCM patients may significantly impact the initial treatment choice and follow-up of heart failure patients.
Indexed as
Identifiers
40841467What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.